Preparation of oxytocin liposomes modified by cell penetrating peptides and evaluation on brain targeting efficiency via intranasal delivery
10.16438/j.0513-4870.2021-0856
- VernacularTitle:细胞穿膜肽修饰的缩宫素脂质体的制备及经鼻入脑的靶向性研究
- Author:
Feng-mei LÜ
;
Hui-min LIANG
;
Li SUI
;
Zhe-peng LIU
- Publication Type:Research Article
- Keywords:
oxytocin;
cell-penetrating peptide;
arginine octamer;
liposome;
mucoadhesive;
nose-to-brain delivery
- From:
Acta Pharmaceutica Sinica
2022;57(2):500-506
- CountryChina
- Language:Chinese
-
Abstract:
The water-soluble polypeptide drug oxytocin was encapsulated in liposomes by reverse-phase evaporation vesicle method to obtain oxytocin loaded liposomes (OT@LPs) which was further modified with cationic cell penetrating peptide—arginine octamer (R8) to get R8 modified oxytocin loaded liposomes (OT@LPs-R8) which showed enhanced mucoadhesive. The brain targeting efficiency was evaluated preliminarily after nasal administration. OT@LPs-R8 showed a round shape with a particle size distribution of 110.2 ± 7.3 nm, a surface potential as high as +18 mV, a drug loading (62.17 ± 1.88) %, an encapsulation rate (5.85 ± 0.72) %, and stood stable in nasal mucus. After nasal administration, it could significantly prolong the retention and enhance the distribution in the brain with no irritation to the nasal mucosa. The animal experiment in line with the regulations of the Department of Laboratory Animal Science of Fudan University on the ethics of animal experiments had been carried out after passing the review of the Animal Ethics Committee of Fudan University. The results showed nasal administration of OT@LPs-R8 could promote oxytocin directly into the brain from the nose which expected to become a new carrier for delivery of oxytocin to the brain.
